OpenVSafe by OpenVAERS
Search V-safe

Y75-11918-73826

3 vaccinations 11 coded responses 31 check-ins 11 free-text entries 9 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
907 / CA
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Registered in v-safe
  2. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-20
    Survey response — day 0, dose 1
    MedDRA: Dizziness, Pruritus — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Itchiness, mild dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-20
    Report sent to call center — day 0, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to work
    Free text: runny nose, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-21
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Diarrhea
    Adult check-in
  8. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Loss of personal independence in daily activities — Feeling: Fair · Be unable to do your normal daily activities
    Free text: dizziness that limited me from normal activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2020-12-25
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  13. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  14. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  16. 2021-01-10
    Survey response — day 0, dose 2
    MedDRA: Dysphagia, Hyperhidrosis, Hypoaesthesia, Paraesthesia, Pruritus — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: itchiness; trouble swallowing; sweating; numbness & tingling in feet
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-10
    Report sent to call center — day 0, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  18. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: swollen glands below the jawline
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  20. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Headache, Joint pains, Muscle or body aches
    Free text: runny nose, congestion in nose, and later in evening congestion in chest
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: sore throat (moderate), runny nose fmild), congestion (mild)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  23. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough — Feeling: Poor · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  25. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Hypoaesthesia, Paraesthesia — Feeling: Poor · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Coughing (dry, no phlegm) and numbness/tingling in feet
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  27. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  28. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  29. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  30. 2021-01-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-01-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  32. 2021-02-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  33. 2021-02-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  34. 2021-02-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  35. 2021-04-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  36. 2021-07-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  37. 2022-01-11
    Dose 3 — Moderna
  38. 2022-01-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  39. 2022-01-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain, Pre-existing disease, Rhinorrhoea — Feeling: Fair
    Free text: Allergies with nasal drainage causing mild sore throat
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-01-20
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  41. 2022-01-25
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-02-01
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-02-08
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-04-12
    Survey response — 3 months, dose 3
    MedDRA: Abdominal pain, Diarrhoea, Fatigue, Feeling abnormal, Headache, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fatigue, not feeling quite myself today. Within the last two weeks I've had 4-5 days of diarrhea, 2 days of abdominal pain, 1-2 days of nausea, 1 day headache and significant fatigue.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-10Pfizer-BioNTech
32022-01-11Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2020-12-20 priority 2/3
2020-12-21 priority 2/3
2020-12-25 priority 2/3
2021-01-10 priority 2/3
2021-01-11 priority 2/3
2021-01-13 priority 2/3
2021-01-14 priority 2/3
2021-01-15 priority 2/3
2021-01-16 priority 2/3

Free text

Release 1 — day 0, dose 1

2020-12-20

Systemic reaction (other): Itchiness, mild dizziness

Release 1 — days 1–6 daily, dose 1

2020-12-21

Systemic reaction (other): runny nose, sore throat

2020-12-25

Systemic reaction (other): dizziness that limited me from normal activities

Release 1 — day 0, dose 2

2021-01-10

Systemic reaction (other): itchiness; trouble swallowing; sweating; numbness & tingling in feet

Release 1 — days 1–6 daily, dose 2

2021-01-11

Systemic reaction (other): swollen glands below the jawline

2021-01-12

Systemic reaction (other): runny nose, congestion in nose, and later in evening congestion in chest

2021-01-13

Systemic reaction (other): sore throat (moderate), runny nose fmild), congestion (mild)

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Coughing

2021-01-15

Systemic reaction (other): Coughing (dry, no phlegm) and numbness/tingling in feet

Release 10 — days 1–6 daily, dose 3

2022-01-17

Systemic reaction (other): Allergies with nasal drainage causing mild sore throat

Release 11 — 3 months, dose 3

2022-04-12

Symptoms: Fatigue, not feeling quite myself today. Within the last two weeks I've had 4-5 days of diarrhea, 2 days of abdominal pain, 1-2 days of nausea, 1 day headache and significant fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDDiarrhoea · · ✓
SDFatigue · · ✓
SDFeeling abnormal · · ✓
SDHeadache · · ✓
SDNausea · · ✓
SROCough ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODysphagia ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROLoss of personal independence in daily activities ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROPre-existing disease · · ✓
SROPruritus ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release